JASON ROBERT WESTIN to Maximum Tolerated Dose
This is a "connection" page, showing publications JASON ROBERT WESTIN has written about Maximum Tolerated Dose.
Connection Strength
0.064
-
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study. Lancet Haematol. 2021 Nov; 8(11):e818-e827.
Score: 0.040
-
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study. Lancet Oncol. 2014 Aug; 15(9):1019-26.
Score: 0.024